ArticleCell stress & chaperones2020

Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?

Edward R O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.